255 related articles for article (PubMed ID: 19404540)
21. Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris.
Lei J; Guan B; Li B; Duan Z; Chen Y; Li H; Jin J
Protein Expr Purif; 2012 Jul; 84(1):154-60. PubMed ID: 22609631
[TBL] [Abstract][Full Text] [Related]
22. Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity.
Wang M; Wang Y; Wang J; Zou M; Liu S; Xu T; Cai X; Wu C; Wang J; Xu D
Biotechnol Lett; 2009 Dec; 31(12):1923-7. PubMed ID: 19685208
[TBL] [Abstract][Full Text] [Related]
23. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of recombinant hirudin.
Nowak G
Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
[TBL] [Abstract][Full Text] [Related]
25. Hirudin as alternative anticoagulant--a historical review.
Markwardt F
Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
[TBL] [Abstract][Full Text] [Related]
26. The comeback of hirudin as an antithrombotic agent.
Markwardt F
Semin Thromb Hemost; 1991 Apr; 17(2):79-82. PubMed ID: 1771415
[No Abstract] [Full Text] [Related]
27. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
Hunt JA; Petteway SR; Scuderi P; Novokhatny V
Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
[TBL] [Abstract][Full Text] [Related]
28. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
Liebe V; Brückmann M; Fischer KG; Haase KK; Borggrefe M; Huhle G
Semin Thromb Hemost; 2002 Oct; 28(5):483-90. PubMed ID: 12420244
[TBL] [Abstract][Full Text] [Related]
29. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.
Fareed J; Walenga JM; Iyer L; Hoppensteadt D; Pifarre R
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):135-47. PubMed ID: 1772981
[TBL] [Abstract][Full Text] [Related]
30. Neutralization of recombinant hirudin: some practical considerations.
Fareed J; Walenga JM; Hoppensteadt D; Iyer L; Pifarre R
Semin Thromb Hemost; 1991 Apr; 17(2):137-44. PubMed ID: 1771411
[No Abstract] [Full Text] [Related]
31. Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor.
Develter J; Dewilde M; Gils A; Declerck PJ
Thromb Haemost; 2009 Jul; 102(1):69-75. PubMed ID: 19572070
[TBL] [Abstract][Full Text] [Related]
32. High-level secretion of dipetarudin, a chimeric thrombin inhibitor, by Pichia pastoris.
Lopez M; Koehler A; Nowak G
Protein Expr Purif; 2007 Mar; 52(1):8-13. PubMed ID: 17157531
[TBL] [Abstract][Full Text] [Related]
33. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
[TBL] [Abstract][Full Text] [Related]
34. Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner.
Peter K; Gupta A; Nordt T; Bauer S; Runge MS; Bode C
J Cardiovasc Pharmacol; 2003 Aug; 42(2):237-44. PubMed ID: 12883328
[TBL] [Abstract][Full Text] [Related]
35. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
Bruno NE; Yano Y; Takei Y; Qin L; Suzuki T; Morser J; D'Alessandro-Gabazza CN; Mizoguchi A; Suzuki K; Taguchi O; Gabazza EC; Sumida Y
Thromb Haemost; 2008 Jul; 100(1):90-100. PubMed ID: 18612543
[TBL] [Abstract][Full Text] [Related]
36. Production and evaluation of recombinant hirudin.
Courtney M; Loison G; Lemoine Y; Riehl-Bellon N; Degryse E; Brown SW; Cazenave JP; Defreyn G; Delebassee D; Bernat A
Semin Thromb Hemost; 1989 Jul; 15(3):288-92. PubMed ID: 2688101
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulant and antithrombotic actions of recombinant hirudin.
Kaiser B
Semin Thromb Hemost; 1991 Apr; 17(2):130-6. PubMed ID: 1837615
[No Abstract] [Full Text] [Related]
38. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological survey of recombinant hirudin.
Markwardt F; Fink G; Kaiser B; Klöcking HP; Nowak G; Richter M; Stürzebecher J
Pharmazie; 1988 Mar; 43(3):202-7. PubMed ID: 3380865
[TBL] [Abstract][Full Text] [Related]
40. [Research progress in hirudin fusion protein--review].
Zhang CL; Yu AP; Jin JD; Wu CT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):215-8. PubMed ID: 17490558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]